Skye Bioscience (SKYE) Other Non-Current Liabilities (2014 - 2022)
Skye Bioscience (SKYE) posted Other Non-Current Liabilities of $326.00 for Q3 2022, down 99.8% from $207,916 a year earlier and down 95.0% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Other Non-Current Liabilities (2014 - 2022) Analysis & Trends
At the end of FY2021, Skye Bioscience's Other Non-Current Liabilities came in at $59,732, up 54.9% from FY2020.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of -45.4% (FY2016 to FY2021).
- In prior years, Skye Bioscience's Other Non-Current Liabilities was $38,567 in FY2020 (-92.3%), $501,400 in FY2019 (-96.9%), $15.96 million in FY2018 and $823,037 in FY2017 (-33.1%).
- The Q3 2022 figure stands as the lowest quarterly Other Non-Current Liabilities in data going back to Q3 2014.
- On a year-over-year basis, Other Non-Current Liabilities has declined in each of the last three quarters, with growth averaging 3.0% over the last eight quarters.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q2 2018, with growth of 840.3%; the weakest was Q3 2022, with a decline of 99.8%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $6,554 (Q2 2022), $16,077 (Q1 2022) and $59,732 (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 326.00 |
| Jun 30, 2022 | 6,554.00 |
| Mar 31, 2022 | 16,077.00 |
| Dec 31, 2021 | 59,732.00 |
| Sep 30, 2021 | 207,916.00 |
| Jun 30, 2021 | 397,565.00 |
| Mar 31, 2021 | 276,917.00 |
| Dec 31, 2020 | 38,567.00 |
| Sep 30, 2020 | 41,149.00 |
| Jun 30, 2020 | 465,287.00 |
| Mar 31, 2020 | 438,934.00 |
| Dec 31, 2019 | 501,400.00 |
| Sep 30, 2019 | 14.31 Mn |
| Jun 30, 2019 | 11.18 Mn |
| Mar 31, 2019 | 29.30 Mn |
| Dec 31, 2018 | 15.96 Mn |
| Sep 30, 2018 | 11.11 Mn |
| Jun 30, 2018 | 10.09 Mn |
| Mar 31, 2018 | 8.59 Mn |
| Dec 31, 2017 | 823,037.00 |
API Access
Skye Bioscience Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();